MedPath
NMPA Approval

Balsalazide Sodium Granules

国药准字H20030748

May 19, 2020

Drug Information

巴柳氮钠颗粒

塞莱得

BIOCAUSE

颗粒剂

2.5g:0.75g(按C17H13N3Na2O6.2H2O计)

化学药品

May 19, 2020

Company Information

Applicant Company

Manufacturing Company

湖北省荆门市杨湾路122号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

巴柳氮钠颗粒 - NMPA 批准文号 | MedPath